Clinical studies confirmed that ADTKD-HNF1β patients have a diminished response to thiazide, confirming lower NCC activity in patients [8]. The gene discussed is SLC12A3; the disease is autosomal dominant medullary cystic kidney disease with or without hyperuricemia.